Clinical course features of newly diagnosed pulmonary tuberculosis treatment failure

被引:0
|
作者
Yasinskyi, R. M. [1 ]
Kovalenko, O. O. [2 ]
Smirnova, V. V. [2 ]
Krasnevich, A. M. [3 ]
机构
[1] Zaporizhzhia State Med Univ, Dept Phthisiol & Pulmonol, Zaporizhia, Ukraine
[2] Zaporizhzhia Reg Council, Municipal Inst Zaporizhzhia Reg Clin TB Dispensar, Pulm TB Dept 1, Zaporizhia, Ukraine
[3] Zaporizhzhia Reg Council, Municipal Inst Zaporizhzhia TB Dispensary 4, Zaporizhia, Ukraine
关键词
Tuberculosis; Treatment Failure;
D O I
10.14739/2310-1210.2016.3.76982
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Percentage of patients with newly diagnosed tuberculosis treatment failure is 22.6 % in the world and is approximately 12% according to the official statistics in Zaporizhzhia. Aim. To establish anamnestic, clinical-radiographic and laboratory features of the tuberculosis course in patients with newly diagnosed tuberculosis treatment failure. Materials and methods. A retrospective analysis of 88 patient's histories who were treated at the Zaporizhzhia Regional Clinical Tuberculosis Dispensary in 2013-2015 years was carried out. Patients were divided into 2 groups: 49 patients with treatment failure (TF) have been included into 1st group, 39 people who successfully completed the course of therapy (NDTB) were in the 2nd group. Results. It was found that 63.3% of TF patients carried fluorography untimely and 26.6% have not been inspected more than 5 years, p<0.05. Infiltrative (55.1%) and disseminative (34.7%) tuberculosis clinical forms in TF patients prevailed in the structure of the lung lesions. Approximately 90% of TF patients had lung lesion volume more than one lobe or both of the lungs (p<0.001) with the presence of several or multiple destructions in 79% of patients with a size greater than 3 cm in 56% of patients compared with the fact, that 46% of patients with NDTB limited tuberculosis diagnosed with single or several destructions with sizes up to 3 cm in 86% cases, p<0.05. When TF percentage of patients with massive bacterial excretion prevailed, p<0.05. In the presence of drug resistance in 70% polyresistance determined, whereas 26% of NDTB bacterial excretion was determined only by culture methods and in resistance cases it was monoresistance in 67% patients. Terms of bacteriological conversion at TF were 6.3 +/- 0.2 months and greater than 6 months in 30.6% of patients. Destruction not healed in 85.4 % of patients, but in most cases, their sizes did not exceed 2 cm at the end of treatment. Long terms of bacteriological conversion and destructions healing in TF patients demonstrate the necessity for long-term etiotropic therapy in patients with smear-massive bacterial excretion and disseminative destructive tuberculosis. The low proportion of destructions healing in these patients determines searchings' for ways to the timely surgical and complex pathogenetic treatment.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 50 条
  • [1] Prevalence, features of the course and treatment efficacy airway obstruction in patients with newly diagnosed pulmonary tuberculosis
    Dudnyk, Andriy
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Changes in the levels of adipokines in newly diagnosed pulmonary tuberculosis patients in case of treatment failure
    Yasinskyi, R. M.
    Raznatovska, O. M.
    ZAPOROZHYE MEDICAL JOURNAL, 2020, 22 (02) : 220 - 225
  • [3] RIFABUTIN IN THE TREATMENT OF NEWLY-DIAGNOSED PULMONARY TUBERCULOSIS
    MITCHISON, DA
    TUBERCLE AND LUNG DISEASE, 1995, 76 (03): : 277 - 277
  • [4] Clinical characteristics of newly diagnosed tuberculosis patients with respiratory failure
    C Permpikul
    S Tongyoo
    W Lekpittaya
    P Thamrongpairoj
    Intensive Care Medicine Experimental, 3 (Suppl 1)
  • [5] CLINICAL OBSERVATIONS IN NEWLY DIAGNOSED CASES OF PULMONARY TUBERCULOSIS DURING 1971
    SIGHART, H
    PRAXIS DER PNEUMOLOGIE, 1974, 28 (10): : 556 - 561
  • [6] Predictors of therapy failure in newly diagnosed pulmonary tuberculosis cases in Beira, Mozambique
    Pizzol D.
    Veronese N.
    Marotta C.
    Di Gennaro F.
    Moiane J.
    Chhaganlal K.
    Monno L.
    Putoto G.
    Mazzucco W.
    Saracino A.
    BMC Research Notes, 11 (1)
  • [7] The effects of smoking on treatment outcome in patients newly diagnosed with pulmonary tuberculosis
    Masjedi, M. R.
    Hosseini, M.
    Aryanpur, M.
    Mortaz, E.
    Tabarsi, P.
    Soori, H.
    Emami, H.
    Heidari, G.
    Dizagie, M. K.
    Baikpour, M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (03) : 351 - 356
  • [8] Clinical Features Affecting The Sensitivity Of Tspot.tb In Newly Diagnosed Smear-Positive Pulmonary Tuberculosis
    Ikeda, M.
    Yamamoto, M.
    Nagakura, H.
    Nakashima, K.
    Watanabe, H.
    Nagai, K.
    Ushio, R.
    Shibata, Y.
    Tashiro, K.
    Horita, N.
    Sato, T.
    Kobayashi, N.
    Kudo, M.
    Shinkai, M.
    Kaneko, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [9] Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis
    McGregor, MM
    Olliaro, P
    Wolmarans, L
    Mabuza, B
    Bredell, M
    Felten, MK
    Fourie, PB
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (05) : 1462 - 1467
  • [10] Impact of diabetes mellitus on clinical parameters and treatment outcomes of newly diagnosed pulmonary tuberculosis patients in Thailand
    Duangrithi, D.
    Thanachartwet, V.
    Desakorn, V.
    Jitruckthai, P.
    Phojanamongkolkij, K.
    Rienthong, S.
    Chuchottaworn, C.
    Pitisuttithum, P.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (11) : 1199 - 1209